Green Cross Medical Science Corporation (142280) — Cash Flow Quality Index
Green Cross Medical Science Corporation (142280) has a Cash Flow Quality Index of -1.11x as of March 2026. Operating cash flow of ₩-160.64 Million is below net income of ₩144.53 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Green Cross Medical Science Corporation service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Green Cross Medical Science Corporation Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Green Cross Medical Science Corporation across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 142280 operating cash flow.
Annual Cash Flow Quality Index for Green Cross Medical Science Corporation (2014–2025)
Year-by-year earnings quality comparison for Green Cross Medical Science Corporation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.96x | ₩7.20 Billion | ₩3.67 Billion | ▲ +82.1% |
| 2024 | 1.08x | ₩3.66 Billion | ₩3.40 Billion | ▼ -52.3% |
| 2023 | 2.26x | ₩4.24 Billion | ₩1.88 Billion | ▲ +273.3% |
| 2020 | -1.30x | ₩-8.76 Billion | ₩6.72 Billion | ▲ +85.6% |
| 2015 | -9.03x | ₩-5.45 Billion | ₩603.26 Million | ▼ -1412.9% |
| 2014 | -0.60x | ₩-2.22 Billion | ₩3.72 Billion | — |